Green Tea Catechin Plus Inulin Improves Insulin Resistance Without Reducing Visceral Fat and Shows Exploratory Gut Microbiota Signals in Adults with Visceral Obesity: A Double-Blind Randomized Controlled Trial
Nutrients · 06.03.2026 · 18 (5) · 851
DOI: 10.3390/nu18050851 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 06.03.2026. Verfasst von Chikara Iino und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan. Hauptthemen laut MEDLINE: Catechin, Inulin, Insulin Resistance, Intra-Abdominal Fat. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JST COI, Kao Corporation.
Abstract (Originalsprache)
Background
Green tea catechins and inulin may improve metabolic health and modulate the gut microbiota; however, double-blind trials evaluating visceral fat, insulin resistance, and microbiota concurrently are limited.
Methods
We conducted a double-blind, parallel-group, randomized, placebo-controlled trial in Japanese adults aged 20–75 years with visceral fat area (VFA) ≥ 80 cm2 and BMI ≥ 23 kg/m2 (trial registration: Japan Registry of Clinical Trials (jRCT), jRCTs021230004 (registered 16 May 2023)). Participants were randomized to a catechin + inulin beverage (catechins 400 mg/day; inulin 2.3 g/day) or placebo for 12 weeks. The primary outcome was the change in VFA (bioelectrical impedance). Secondary outcomes included HOMA-IR, metabolic markers, liver fat assessed by the controlled attenuation parameter (CAP), and genus-level gut microbiota.
Results
Ninety-six participants were randomized (catechin + inulin, n = 49; placebo, n = 47); 47 and 44, respectively, were included in the full analysis set for the primary outcome. The 12-week change in VFA did not differ between groups (mean change: +0.91 vs. +4.61 cm2; p = 0.243). HOMA-IR decreased in the catechin + inulin group and increased in the placebo group, yielding a significant between-group difference (mean change: −0.32 vs. +0.18; p = 0.020). No other secondary outcomes showed significant between-group differences. In exploratory microbiota analyses, no genus remained significant after false discovery rate correction; however, Coprococcus and Bifidobacterium showed nominal between-group differences (unadjusted p < 0.05). Changes in Coprococcus were inversely correlated with changes in HOMA-IR (r = −0.28; p = 0.010).
Conclusions
Catechin plus inulin for 12 weeks did not reduce visceral fat but was associated with improved insulin resistance. Exploratory analyses suggest a potential association between increased Coprococcus and improved HOMA-IR, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
- Human Health Care Products Research Laboratories, Kao Corporation, Tokyo 131-8501, Japan.
- Research Center for Health-Medical Data Science, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
- Department of Active Life Promotion Sciences, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
- Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo 108-0071, Japan.
- Research Institute of Health Innovation, Hirosaki University, Hirosaki 036-8562, Japan.
ORCID-Profile: Chikara Iino, Satoshi Sato, Kenta Yoshida, Tohru Yamaguchi, Hiroto Bushita, Keita Kinoshita, Yuji Matsui, Seiya Imoto, Yoshinori Tamada, Shigeyuki Nakaji, Tatsuya Mikami
Förderung
- JST COI
- Kao Corporation
Zitieren
APA
Iino, C., Mikami, K., Furusawa, K., Sato, S., Yoshida, K., Yamaguchi, T., Bushita, H., Kinoshita, K., Matsui, Y., Imoto, S., Iwane, T., Tamada, Y., Murashita, K., Nakaji, S., Mikami, T., & Sakuraba, H. (2026). Green Tea Catechin Plus Inulin Improves Insulin Resistance Without Reducing Visceral Fat and Shows Exploratory Gut Microbiota Signals in Adults with Visceral Obesity: A Double-Blind Randomized Controlled Trial. Nutrients, 18(5), 851. https://doi.org/10.3390/nu18050851
Vancouver
Iino C, Mikami K, Furusawa K, Sato S, Yoshida K, Yamaguchi T, et al. Green Tea Catechin Plus Inulin Improves Insulin Resistance Without Reducing Visceral Fat and Shows Exploratory Gut Microbiota Signals in Adults with Visceral Obesity: A Double-Blind Randomized Controlled Trial. Nutrients. 2026;18(5):851. doi:10.3390/nu18050851
BibTeX
@article{Iino2026,
author = {Iino, Chikara and Mikami, Keita and Furusawa, Keisuke and Sato, Satoshi and Yoshida, Kenta and Yamaguchi, Tohru and Bushita, Hiroto and Kinoshita, Keita and Matsui, Yuji and Imoto, Seiya and Iwane, Takuro and Tamada, Yoshinori and Murashita, Koichi and Nakaji, Shigeyuki and Mikami, Tatsuya and Sakuraba, Hirotake},
title = {Green Tea Catechin Plus Inulin Improves Insulin Resistance Without Reducing Visceral Fat and Shows Exploratory Gut Microbiota Signals in Adults with Visceral Obesity: A Double-Blind Randomized Controlled Trial},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {5},
pages = {851},
doi = {10.3390/nu18050851}
}
EUVIMED